← Back
$JANX All transactions

Janux Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$100K

Shares

3,333

Price

$30

Filed

Nov 14

Insider

Name

Meyer Andrew Hollman

Title

Chief Business Officer

CIK

0001864159

Roles

Officer

Transaction Details

Transaction Date

2025-11-14

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

84,974

Footnotes

Includes 1 share acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on November 15, 2024 and 2,834 shares acquired under the Plan on May 15, 2025. | The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024. | Immediately exercisable.

Filing Info

Accession No.

0001864159-25-000005

Form Type

4

Issuer CIK

0001817713

Meyer Andrew Hollman's History

Date Ticker Type Value
2026-01-02 JANX $26K
2025-12-01 JANX M $35K
2025-12-01 JANX $89K
2025-12-01 JANX $21K
2025-12-01 JANX M $0
2025-11-14 JANX M $35K
2025-11-14 JANX $100K
2025-11-14 JANX M $0
2025-10-28 JANX M $42K
2025-10-28 JANX M $71K

Other Insiders at JANX (90d)

Insider Bought Sold Last
Go William
Chief Medical Officer
2026-02-02